JBCHEPHARMJB Chemicals & Pharmaceuticals Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹2,408.90
0.00%Strong
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)39,940.60
P/E55.86
P/B9.60
PEG—
ROE %18.69
ROCE %21.60
Debt / Equity0.00
EPS44.53
Revenue Growth %-4.80
Profit Growth %-31.00
Dividend Yield %1.16
Promoter Holding %49.23
FII Holding %30.81
DII Holding %—
Beta-0.02
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 80% | ₹2,408.90 | ₹2,354.99 | ₹2,502.90 | 1.74 |
BUYConviction 78%
Why buy
- • ROE: 18.7%
- • ROCE: 21.6%
- • Debt/Equity: 0.00
- • RSI: 61
- • MACD: bullish
- • Price vs EMA21: above
- • Pullback to 21-EMA signal (setup quality 80%)
Bull case
- • ROE: 18.7%
- • ROCE: 21.6%
- • Debt/Equity: 0.00
- • RSI: 61
Bear case
- • Revenue growth: -4.8% YoY
- • Profit growth: -31.0% YoY
- • Volume: 0.0x 20-day average
- • Beta: -0.02
Key risks
- • Revenue growth: -4.8% YoY
- • Profit growth: -31.0% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹2,408.90
Stop Loss
₹2,274.12
risk 5.6%
Target 1 (1.5R)
₹2,611.07
+8.4%
Target 2 (3R)
₹2,813.24
+16.8%
Support (20d)
₹2,163.10
Resistance (52w)
₹2,525.50
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹134.78/share
ATR (volatility)
₹53.91
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹53.91). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
52
Technical
76
Momentum
92
Risk (safety)
83